Skip to main navigation Skip to search Skip to main content

Relations between C9orf72 expansion size in blood, age at onset, age at collection and transmission across generations in patients and presymptomatic carriers

  • Clémence Fournier
  • , Mathieu Barbier
  • , Agnès Camuzat
  • , Vincent Anquetil
  • , Serena Lattante
  • , Fabienne Clot
  • , Cécile Cazeneuve
  • , Daisy Rinaldi
  • , Philippe Couratier
  • , Vincent Deramecourt
  • , Mario Sabatelli
  • , Serge Belliard
  • , Martine Vercelletto
  • , Sylvie Forlani
  • , Ludmila Jornea
  • , Alexis Brice
  • , Sophie Auriacombe
  • , Frédéric Blanc
  • , Claire Bouteleau-Bretonnière
  • , Mathieu Ceccaldi
  • Mira Didic, Bruno Dubois, Charles Duyckaerts, Frédérique Etcharry-Bouix, Véronique Golfier, Didier Hannequin, Lucette Lacomblez, Isabelle Le Ber, Richard Levy, Bernard François Michel, Florence Pasquier, Catherine Thomas-Anterion, Jérémie Pariente, François Sellal, Eve Benchetrit, Hugo Bertin, Anne Bertrand, Anne Bissery, Stéphanie Bombois, Marie Paule Boncoeur, Pascaline Cassagnaud, Mathieu Chastan, Yaohua Chen, Marie Chupin, Olivier Colliot, Xavier Delbeucq, Christine Delmaire, Emmanuel Gerardin, Claude Hossein-Foucher, Pierre François Pradat, French Clinical and Genetic Research Network on FTLD/FTLD-ALS, PREVDEMALS and FTLD-Exome Study Groups

Research output: Contribution to journalArticlepeer-review

Abstract

A (GGGGCC)n repeat expansion in C9orf72 gene is the major cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The relations between the repeats size and the age at disease onset (AO) or the clinical phenotype (FTD vs. ALS) were investigated in 125 FTD, ALS, and presymptomatic carriers. Positive correlations were found between repeats number and the AO (p < 10e−4) but our results suggested that the association was mainly driven by age at collection (p < 10e−4). A weaker association was observed with clinical presentation (p = 0.02), which became nonsignificant after adjustment for the age at collection in each group. Importantly, repeats number variably expanded or contracted over time in carriers with multiple blood samples, as well as through generations in parent-offspring pairs, conversely to what occurs in several expansion diseases with anticipation at the molecular level. Finally, this study establishes that measure of repeats number in lymphocytes is not a reliable biomarker predictive of the AO or disease outcome in C9orf72 long expansion carriers.

Original languageEnglish
Pages (from-to)234.e1-234.e8
JournalNeurobiology of Aging
Volume74
DOIs
Publication statusPublished (in print/issue) - 1 Feb 2019

Funding

The authors thank the DNA and cell bank of the ICM, Hopital Pitié-Salpêtrière, Paris. The authors are very grateful to the Adrian Isaac's team (UCL, London) for their technical advices. Funding sources: The research leading to these results has received funding from the program “Investissements d'avenir” ANR-10-IAIHU-06. This work was partially funded by the Program Hospitalier de Recherche Clinique FTLD-exome (to ILB., promotion Assistance Publique–Hôpitaux de Paris) and by the ANR-PRTS PREV-DEMALS project (to ILB, promotion by Assistance Publique–Hôpitaux de Paris). The French Clinical and Genetic Research Network on FTLD/FTLD-ALS includes: Alexis Brice (Hôpital de la Salpêtrière, Paris), Sophie Auriacombe (CHU Pellegrin, Bordeaux), Serge Belliard (CHU Rennes), Frédéric Blanc (Hôpitaux Civils, Strasbourg), Claire Bouteleau-Bretonnière (CHU Laennec, Nantes), Mathieu Ceccaldi (CHU La Timone, Marseille), Philippe Couratier (CHU Limoges), Mira Didic (CHU La Timone, Marseille), Bruno Dubois (Hôpital de la Salpêtrière, Paris), Charles Duyckaerts (Hôpital de la Salpêtrière, Paris), Frédérique Etcharry-Bouix (CHU Angers), Véronique Golfier (CHU Rennes), Didier Hannequin (CHU Charles Nicolle, Rouen), Lucette Lacomblez (Hôpital de la Salpêtrière, Paris), Isabelle Le Ber (Hôpital de la Salpêtrière, Paris), Richard Levy (Hôpital de la Salpêtrière, Paris), Bernard-François Michel (CH Sainte-Marguerite, Marseille), Florence Pasquier (CHU Roger Salengro, Lille), Catherine Thomas-Anterion (Plein-Ciel, Lyon), Jérémie Pariente (CHU Rangueil, Toulouse), François Sellal (CH Colmar), Martine Vercelletto (CHU Laennec, Nantes). PREVDEMALS & FTLD-Exome Study Groups include: Eve Benchetrit (Hôpital Pitié-Salpêtrière, Paris), Hugo Bertin (Hôpital de la Salpêtrière, Paris), Anne Bertrand (Hôpital Pitié-Salpêtrière, Paris), Anne Bissery (Hôpital Pitié-Salpêtrière, Paris), Stéphanie Bombois (CHU Roger Salengro, Lille), Marie-Paule Boncoeur (CHU Limoges), Pascaline Cassagnaud (CHU Roger Salengro, Lille), Mathieu Chastan (CHU Charles Nicolle, Rouen), Yaohua Chen (CHU Roger Salengro, Lille), Marie Chupin (CATI, ICM, Paris), Olivier Colliot (ICM, Paris), Philippe Couratier (CHU Limoges), Xavier Delbeucq (CHU Roger Salengro, Lille), Vincent Deramecourt (CHU Roger Salengro, Lille), Christine Delmaire (CHU Roger Salengro, Lille), Emmanuel Gerardin (CHU Charles Nicolle, Rouen), Claude Hossein-Foucher (CHU Roger Salengro, Lille), Bruno Dubois (Hôpital Pitié-Salpêtrière, Paris), Marie-Odile Habert (Hôpital Pitié-Salpêtrière, Paris), Didier Hannequin (CHU Charles Nicolle, Rouen), Géraldine Lautrette (CHU Limoges), Thibaud Lebouvier (CHU Roger Salengro, Lille), Isabelle Le Ber (Hôpital Pitié-Salpêtrière Salpêtrière, Paris), Stéphane Lehéricy (Hôpital Pitié-Salpêtrière Salpêtrière, Paris), Benjamin Le Toullec (ICM, Paris), Richard Levy (Hôpital Pitié-Salpêtrière, Paris), Kelly Martineau (CATI, ICM, Paris), Marie-Anne Mackowiak (CHU Roger Salengro, Lille), Jacques Monteil (CHU Limoges), Florence Pasquier (CHU Roger Salengro, Lille), Grégory Petyt (CHU Roger Salengro, Lille), Pierre-François Pradat (Hôpital Pitié-Salpêtrière, Paris), Assi-Hervé Oya (Hôpital Pitié-Salpêtrière, Paris), Daisy Rinaldi (Hôpital Pitié-Salpêtrière, Paris), Adeline Rollin-Sillaire (CHU Roger Salengro, Lille), François Salachas (Hôpital Pitié-Salpêtrière, Paris), Sabrina Sayah (Hôpital Pitié-Salpêtrière, Paris), David Wallon (CHU Rouen). Appendix A

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Amyotrophic Lateral sclerosis
  • Anticipation
  • C9orf72
  • Frontotemporal dementia
  • Frontotemporal lobar degeneration
  • TDP-43

Fingerprint

Dive into the research topics of 'Relations between C9orf72 expansion size in blood, age at onset, age at collection and transmission across generations in patients and presymptomatic carriers'. Together they form a unique fingerprint.

Cite this